FGF2 and Stroke: Our study showed that modification with SVV enhanced survival of the transplanted MSCs, further upregulated expression of VEGF and bFGF in the cerebral ischemic tissues, reduced the infarct volume and finally further improved the neurological functional recovery in a rat model of stroke.